ASBP Aspire-Lakewood Holdings, Inc.
$8.44▲ +3.43%
Healthcare
Other
Volume 9.7K
Avg Volume (10D) 35.5K
Key Metrics & Fundamentals
Market Cap
$11.84M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.11 - 18.76
% vs 50 MA
-0.84%
% vs 200 MA
78.22%
RSI-14
49.3
MACD Histogram
-0.0100
Beta (1Y vs SPY)
5.95
Free Cash Flow
-$2.12M
Gross Rev
$63,104
Gross Profit
-$30,086
EBITDA
-$2.39M
COGS
$93,190
Operating Exp
$2.42M
Operating Income
-$2.45M
EBIT
-$2.45M
Pretax Income
-$1.27M
Net Income
-$1.27M
EPS (Diluted)
-1.22
Price & Volume History
Loading chart…
Recent News
Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program
ACCESS Newswire · Sep 9, 2026 8:30 AM ET
Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.
ACCESS Newswire · Sep 8, 2026 9:00 AM ET
Sidoti Events, LLC's August Micro-Cap Virtual Conference
ACCESS Newswire · Aug 18, 2026 10:00 AM ET
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
ACCESS Newswire · Aug 13, 2026 8:15 AM ET
EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal
Benzinga · Aug 10, 2026 10:31 PM ET
Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue
ACCESS Newswire · Aug 10, 2026 8:30 AM ET
EXCLUSIVE: Aspire Biopharma Buys Its Way Into Global Auto Market With $30 Million DCS Deal
Benzinga · Aug 10, 2026 8:16 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ASBP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.